Ham Jeong-yeop is the founder of NeoCannBio. NeoCannBio has raised $11M in total funding. Latest round: Series B. Based in Seoul, South Korea.
Ham Jeong-yeop (함정엽) is the founder and current CEO of NeoCannBio (네오켄바이오), a South Korean biotech company established in June 2021 that develops CBD-based new drugs for intractable brain diseases such as epilepsy using medical hemp. The company, backed by the Korea Institute of Science and Technology (KIST), raised a cumulative total of 15 billion won (approx. $11.3M) in funding within two years of its founding, including a 10 billion won Series B round in September 2023. His role as the company's representative is confirmed by corporate records listing him as the current CEO.
Full founder directory · Investor directory · Company funding database · Fundraising library